Concord Biotech Ltd.'s market cap is currently ₹170.35B. The company's EPS TTM is ₹4.2; its P/E ratio is 47.84; and it has a dividend yield of 0.66%. Concord Biotech Ltd. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ₹4.80. See an overview of income statement, balance sheet, and cash flow financials.
